MW 343.9 Da, Purity >98%. Potent agonist at four sphingosine-1-phosphate (S1P) receptors (S1P1, S1P3, S1P4, and S1P5). Novel immunomodulator able to block T-cell egress from lymph nodes. Structural analog of sphingosine. Orally active in vivo.
CD363, CHEDG 1, D1S3362, ECGF 1, EDG 1, Endothelial differentiation G-protein coupled receptor 1, Endothelial differentiation sphingolipid G protein coupled receptor 1, FLJ58121, G protein coupled sphingolipid receptor, S1P receptor 1, S1P receptor Edg-1, S1P(1) receptor, S1P1, S1PR1_HUMAN, Sphingosine 1-phosphate receptor 1, Sphingosine 1-phosphate receptor Edg-1, Sphingosine 1phosphate receptor type 1 S1P1, g protein-coupled receptor edg-1, sphingolipid g-protein-coupled receptor 1
MW 343.9 Da, Purity >98%. Potent agonist at four sphingosine-1-phosphate (S1P) receptors (S1P1, S1P3, S1P4, and S1P5). Novel immunomodulator able to block T-cell egress from lymph nodes. Structural analog of sphingosine. Orally active in vivo.
Soluble in DMSO to 100 mM.
Soluble in ethanol to 100 mM (with warming).
Potent agonist at four sphingosine-1-phosphate (S1P) receptors (S1P1, S1P3, S1P4, and S1P5). Novel immunomodulator able to block T-cell egress from lymph nodes. Structural analog of sphingosine. Orally active in vivo.
The S1P1 receptor also known as EDG1 is a G-protein-coupled receptor that plays a significant role in the sphingosine-1-phosphate (S1P) signaling pathway. With a molecular mass of approximately 43 kDa S1P1 is expressed in various tissues such as vascular endothelial cells immune cells and cardiac cells. The protein mediates the effects of sphingosine-1-phosphate a bioactive lipid that participates in various physiological processes.
S1P1 is involved in the regulation of immune cell trafficking and vascular stability. As a part of a receptor complex it activates intracellular signaling cascades that influence cell migration and vascular maturation. By binding to S1P S1P1 controls the egress of lymphocytes from lymphoid tissues indicating its important role in immune surveillance and response.
S1P1 serves as an important component in the S1P signaling pathway and the phosphoinositide 3-kinase (PI3K) pathway. In the S1P pathway it regulates endothelial cell barrier function and vascular maturation. In the PI3K pathway S1P1 influences cell survival and migration which relates it to protein kinases like Akt and other signaling molecules that further modify cellular responses.
S1P1 is implicated in multiple sclerosis (MS) and cancer progression. In MS S1P1 modulation affects lymphocyte trafficking which is the mechanism behind the action of fingolimod (FTY720) a therapeutic agent for the disease. S1P1 also connects to VEGF and other angiogenic factors in cancer where it influences tumor angiogenesis and metastasis. Understanding these connections highlights the potential for targeting S1P1 in therapeutic strategies for these conditions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab142065, Fingolimod (FTY720), S1P receptor modulator
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com